These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38789351)

  • 1. A Clinical Review of Vasopressors in Emergency Medicine.
    Stampfl M; DeBlieux P
    J Emerg Med; 2024 Jul; 67(1):e31-e41. PubMed ID: 38789351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressor agents in shock.
    Moyer JH; Mills LC
    Am J Nurs; 1975 Apr; 75(4):620-5. PubMed ID: 1039254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressors for hypotensive shock.
    Gamper G; Havel C; Arrich J; Losert H; Pace NL; Müllner M; Herkner H
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD003709. PubMed ID: 26878401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and Outcomes of Peripheral Vasopressors in Early Sepsis-Induced Hypotension Across Michigan Hospitals: A Retrospective Cohort Study.
    Munroe ES; Heath ME; Eteer M; Gershengorn HB; Horowitz JK; Jones J; Kaatz S; Tamae Kakazu M; McLaughlin E; Flanders SA; Prescott HC
    Chest; 2024 Apr; 165(4):847-857. PubMed ID: 37898185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of cardiovascular instability in patients receiving various vasopressor strategies for peri-intubation hypotension.
    Schmitt CJ; Mattson AE; Brown CS; Mara KC; Cabrera D; Sandefur BJ; Wieruszewski ED
    Am J Emerg Med; 2023 Mar; 65():104-108. PubMed ID: 36603354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressor use in adult patients.
    Ferguson-Myrthil N
    Cardiol Rev; 2012; 20(3):153-8. PubMed ID: 22318007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are vasopressors useful in toxin-induced cardiogenic shock?
    Skoog CA; Engebretsen KM
    Clin Toxicol (Phila); 2017 Apr; 55(4):285-304. PubMed ID: 28152638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressors for shock.
    Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
    Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressors for hypotensive shock.
    Lampard JG; Lang E
    Ann Emerg Med; 2013 Mar; 61(3):351-2. PubMed ID: 23026787
    [No Abstract]   [Full Text] [Related]  

  • 12. How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock.
    Teja B; Bosch NA; Walkey AJ
    Chest; 2023 Mar; 163(3):567-574. PubMed ID: 36162481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock.
    Morales DL; Gregg D; Helman DN; Williams MR; Naka Y; Landry DW; Oz MC
    Ann Thorac Surg; 2000 Jan; 69(1):102-6. PubMed ID: 10654495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive vasopressors in distributive shock: How soon is early?
    Garcia B; Legrand M
    Crit Care; 2023 May; 27(1):210. PubMed ID: 37254175
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of vasopressor agents in critically ill patients.
    Kellum JA; Pinsky MR
    Curr Opin Crit Care; 2002 Jun; 8(3):236-41. PubMed ID: 12386503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressors for hypotensive shock.
    Havel C; Arrich J; Losert H; Gamper G; Müllner M; Herkner H
    Cochrane Database Syst Rev; 2011 May; (5):CD003709. PubMed ID: 21563137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy B; Buzon J; Kimmoun A
    Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT.
    Mouncey PR; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Lamontagne F; Rowan KM;
    Health Technol Assess; 2021 Feb; 25(14):1-90. PubMed ID: 33648623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
    Bosch NA; Teja B; Wunsch H; Walkey AJ
    Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.